Cohort Study on Refractive Errors in Preschool Children (PREC)
Refractive error is a common visual disorder encompassing myopia, hyperopia, astigmatism and other subtypes. Refractive error in preschool children refers to refractive abnormalities occurring during the preschool period (0-6 years old). Studies conducted across diverse regions and populations report that the prevalence of refractive error among preschool children ranges approximately from 10% to 30%, with this proportion showing a gradual upward trend in recent years. Existing evidence suggests that preschool refractive status is correlated with multiple ocular and systemic diseases. Furthermore, the preschool years represent a highly sensitive window for children's visual development; uncorrected refractive errors at this stage can disrupt visual maturation and induce permanent visual impairment. Accordingly, identifying the full spectrum of comorbidities associated with preschool refractive error, alongside implementing early diagnosis and intervention, is clinically critical.
Nevertheless, substantial challenges persist in the clinical management of preschool refractive errors: the complete comorbidity spectrum remains undefined, its natural history has not been fully elucidated, and high-quality evidence-based guidelines for refractive correction and visual rehabilitation are lacking. Establishing a prospective cohort of preschool children with refractive errors is therefore of great significance for clarifying disease progression and risk factors, generating evidence for standardized refractive interventions and visual rehabilitation protocols, and ultimately preventing visual impairment and improving quality of life in this vulnerable pediatric population.
Our research team has previously completed preliminary investigations characterizing myopia in preschoolers. Building on this foundational work, we aim to construct a dedicated cohort of preschool children with refractive errors to delineate the natural history, progression risks and comorbidity profiles of preschool refractive error, and explore effective refractive correction and visual rehabilitation approaches for affected young children.
Przegląd badań
Status
Warunki
Typ studiów
Zapisy (Szacowany)
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Xiao Yang
- Numer telefonu: 13760766303
- E-mail: yangx_zoc@163.com
Lokalizacje studiów
-
-
Guanzhou
-
Guangdong, Guanzhou, Chiny, 510060
- Zhongshan Ophthalmic Center Sun Yat-Sen University
-
Kontakt:
- Xiao Yang
- Numer telefonu: 13760766303
- E-mail: yangx_zoc@163.com
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dziecko
Akceptuje zdrowych ochotników
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- Onset of refractive error occurs during preschool age (0-6 years old) supported by retrievable medical records;
- Spherical equivalent power ≤ -0.50 D or ≥ +3.00 D in any meridian;
- Legal guardians agree to participate and sign written informed consent.
Exclusion Criteria:
Children unable to cooperate with examinations and follow-up visits.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
|---|
|
Refractive error
Refractive error in preschool children
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Ocular Biometry Parameters
Ramy czasowe: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
A set of objective ocular structural measurements mainly including axial length (AL), alongside corneal curvature, anterior chamber depth, lens thickness and vitreous chamber depth.
Axial length, the core indicator in this study, refers to the linear distance from the anterior corneal surface to the retinal pigment epithelium, which is closely associated with the onset and progression of refractive errors in preschool children.
All biometric indices will be measured using standardized ophthalmic biometry equipment at each follow-up visit to dynamically observe the developmental rules of ocular dimensions and their correlation with refractive status.
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
BCVA
Ramy czasowe: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Visual Acuity Examination
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
Contrast Sensitivity
Ramy czasowe: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
CSF
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
SER
Ramy czasowe: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Spherical Equivalent Refraction，Comprehensive index reflecting overall ocular refractive status, integrating myopia, hyperopia and astigmatism.
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
WES (Whole Exome Sequencing)
Ramy czasowe: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Genetic sequencing results of all protein-coding regions to detect gene variants related to refractive disorders.
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
|
OCT
Ramy czasowe: From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
OCT Imaging Findings
|
From date of enrollment until the date of loss to follow-up from any cause, whichever came first, assessed up to 36 months
|
Współpracownicy i badacze
Współpracownicy
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Szacowany)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 2023KYPJ340-2
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .